Sunday, 21 August 2011

Pancreas(to understand diabetes melitus...u must understand this!!!!)...very simple explanation for Staff nurses and medical students!!!!!!!!

What is the function of the pancreas?


The pancreas is small gland (weighing less than 8oz) located close to the stomach. The pancreas has two main functions. It contains clusters of cells (islets of Langerhans) that secrete the pancreatic endocrine hormones insulin and glucagon into the bloodstream in order to regulate blood glucose levels. In addition, the pancreas plays an important role in food digestion,secreting enzymes that break down fat,starch and proteins in the small intestine (duodenum).

How the pancreas regulates blood glucose?

The pancreas contains thousands of clusters of cells (islets of Langerhaans) - divided into two types,beta cells and alpha cells that secrete the hormones insulin and glucagon into the bloodstream. Whtn glucose levels in the bloodstream rise - eg. after eating - the pancreatic beta cells secrete insulin.The insulin stimulates cells in the body to grab the passing glucose,leading toa fall in blood glucose levels. The insulin also instructs the liver to grab glucose and convert it into the glucose-reserve known as glycogen. Conversely, when glucose levels in the bloodstream fall below a set point, alpha cells in the pancreas release the hormone glucagon which tells the liver to re-convert glycogen back to glucose and release it into the bloodstream. These two pancreatic hormones, insulin and glucogon,help to maintain blood glucose levels within heathy parameters


The pancreas contains thousands of clusters of cells (islets of Langerhaans) - divided into two types,beta cells and alpha cells that secrete the hormones insulin and glucagon into the bloodstream. Whtn glucose levels in the bloodstream rise - eg. after eating - the pancreatic beta cells secrete insulin.The insulin stimulates cells in the body to grab the passing glucose,leading toa fall in blood glucose levels. The insulin also instructs the liver to grab glucose and convert it into the glucose-reserve known as glycogen. Conversely, when glucose levels in the bloodstream fall below a set point, alpha cells in the pancreas release the hormone glucagon which tells the liver to re-convert glycogen back to glucose and release it into the bloodstream. These two pancreatic hormones, insulin and glucogon,help to maintain blood glucose levels within heathy parameters.

Tuesday, 19 July 2011

What is Gastritis?Let me tell you the secret......

Definition:
Gastritis is an inflammation (irritation and swelling) of the lining of the stomach

Symptoms:
  • Abdominal pain
  • Dark stools
  • Loss of appetite
  • Nausea
  • Vomiting
  • Vomiting blood or coffee-ground like material
Causes and Risks:

There are many causes of gastritis.

Most common causes:
  • Alcohol
  • Erosion (loss) of the protective layer of the stomach lining
  • Infection of the stomach with Helicobacter pylori  bacteria
  • Medications such as aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Smoking

Less common causes are:
  • Autoimmune disorders (such as pernicious anemia)
  • Backflow of bile  into the stomach (bile reflux)
  • Eating or drinking caustic or corrosive substances (such as poisons)
  • Excess gastric acid  secretion (such as from stress)
  • Viral infection, especially in people with a weak immune system
Gastritis can last a short time (acute gastritis ) or for months to years (chronic gastritis ).

Tests & Diagnostics

Tests vary depending on the specific cause. An X-ray of the upper digestive tract, OGDS(esophagealgastroduodenoscopy), or other tests may be advised.

OGDS-will explain in another article

Treatments

Treatment depends on the specific cause. Some of the causes will disappear over time. Medications to neutralize stomach acid or decrease its production may be recommended

Prevention

Avoid long-term use of irritants (such as aspirin, anti-inflammatory drugs, or alcohol)

Saturday, 30 April 2011

Obesity

Obesity is excess body fat; consequences depend not only on the absolute amount but also on the distribution of the fat. Complications include cardiovascular disorders, diabetes mellitus, many cancers, cholelithiasis, fatty liver and cirrhosis, osteoarthritis, reproductive disorders in men and women, psychologic disorders, and premature death. Diagnosis is based on body mass index (BMI—calculated from height and weight) and waist circumference. BP, fasting plasma glucose, and lipid levels should be measured. Treatment includes physical activity, dietary and behavioral modification, and sometimes drugs or surgery.
Prevalence of obesity in the US is high and is increasing, particularly among children and adolescents Prevalence is more than twice as high at age 55 as at age 20. Obesity is twice as common among women in a lower socioeconomic group as among those in a higher group. Prevalence among black and white men does not differ significantly, but it is higher among black women than white women. More than 50% of black women 40 yr are obese; > 80% are overweight.
In the US, obesity and its complications cause as many as 300,000 premature deaths each year, making it second only to cigarette smoking as a preventable cause of death.

Table 1
Changes in Prevalence of Obesity According to NHANES
Age Group
1976–1980
2003–2004
2–5 yr
5 %
13.9 %
6–11 yr
6.5 %
18.8 %
12–19 yr
5 %
17.4 %
20–74 yr
15 %
32.9 %
NHANES = National Health and Nutrition Examination Surveys.

Etiology
Almost all cases of obesity result from a combination of genetic predisposition and a chronic imbalance between energy intake, energy utilization for basic metabolic processes, and energy expenditure from physical activity.
Genetic factors: Heritability of BMI is about 66%. Genetic factors may affect the many signaling molecules and receptors used by parts of the hypothalamus and GI tract to regulate food intake.Rarely, obesity results from abnormal levels of peptides that regulate food intake (eg, leptin) or abnormalities in their receptors (eg, melanocortin-4 receptor).
Genetic factors also regulate energy expenditure, including BMR, diet-induced thermogenesis, and nonvoluntary activity–associated thermogenesis. Genetic factors may have a greater effect on the distribution of body fat, particularly abdominal fat than on the amount of body fat.

Sidebar 1
Pathways Regulating Food Intake
Preabsorptive and postabsorptive signals from the GI tract and changes in plasma nutrient levels provide short-term feedback to regulate food intake:
  • GI hormones (eg, glucagon-like peptide 1 [GLP-1], cholecystokinin [CCK]) reduce food intake.
  • Ghrelin, secreted primarily by the stomach, increases food intake.
  • Leptin, secreted from adipose tissue, informs the brain as to how much fat is stored; high leptin levels correlate with increased body fat.

The hypothalamus integrates various signals involved in the regulation of energy balance and then activates pathways that increase or decrease food intake:
  • Neuropeptide Y (NPY), agouti-related peptide (ARP), α-melanocyte-stimulating hormone (α-MSH), cocaine- and amphetamine-related transcript (CART), orexin, and melanin-concentrating hormone (MCH) increase food intake.
  • Corticotropic hormone (CRH) and urocortin decrease it.

Environmental factors: Weight is gained when caloric intake exceeds energy needs. Important determinants of energy intake include portion sizes and the energy density of the food. High-fat foods, processed foods, and diets high in refined carbohydrates, soft drinks, fruit juices, and alcohol promote weight gain. Diets high in fresh fruit and vegetables, fiber, and complex carbohydrates, with water as the main fluid consumed, minimize weight gain. A sedentary lifestyle promotes weight gain.
Regulatory factors: Prenatal maternal obesity, prenatal maternal smoking, intrauterine growth restriction, and insufficient sleep can disturb weight regulation. About 15% of women permanently gain 20 lb with each pregnancy. Obesity that persists beyond early childhood makes weight loss in later life more difficult.
Drugs, including corticosteroids, lithium Some Trade Names
ESKALITH
LITHOBID
LITHONATE
,traditional antidepressants (tricyclics, tetracyclics, and monoamine oxidase inhibitors [MAOIs]), benzodiazepines, and antipsychotic drugs, often cause weight gain.
Uncommonly, weight gain is caused by one of the following disorders:
  • Brain damage caused by a tumor (especially a craniopharyngioma) or an infection (particularly those affecting the hypothalamus), which can stimulate consumption of excess calories
  • Hyperinsulinism due to pancreatic tumors
  • Hypercortisolism due to Cushing's syndrome, which produces predominantly abdominal obesity
  • Hypothyroidism (rarely a cause of substantial weight gain)

Eating disorders: At least 2 pathologic eating patterns may be associated with obesity:
  • Binge eating disorder is consumption of large amounts of food quickly with a subjective sense of loss of control during the binge and distress after it .This disorder does not include compensatory behaviors, such as vomiting. Prevalence is 1 to 3% among both sexes and 10 to 20% among people entering weight reduction programs. Obesity is usually severe, large amounts of weight are frequently gained or lost, and pronounced psychologic disturbances are present.
  • Night-eating syndrome consists of morning anorexia, evening hyperphagia, and insomnia. At least 25 to 50% of daily intake occurs after the evening meal. About 10% of people seeking treatment for severe obesity may have this disorder. Rarely, a similar disorder is induced by use of a hypnotic such as zolpidem Some Trade Names
    AMBIEN

Similar but less extreme patterns, classified as eating disorders not otherwise specified (EDNOS), probably contribute to excess weight gain in more people. For example, nocturnal eating contributes to excess weight gain in many people who do not have night-eating syndrome.
Complications
Complications of obesity include the following:
  • Metabolic syndrome
  • Diabetes mellitus
  • Cardiovascular disease
  • Nonalcoholic steatohepatitis (fatty liver)
  • Gallbladder disease
  • Gastroesophageal reflux
  • Obstructive sleep apnea
  • Reproductive system disorders
  • Many cancers
  • Osteoarthritis
  • Social and psychologic problems

Insulin resistance, dyslipidemias, and hypertension (the metabolic syndrome) develop, often leading to diabetes mellitus and coronary artery disease .These complications are more likely in patients with fat that is concentrated abdominally, a high plasma triglyceride level, a family history of type 2 diabetes mellitus or premature cardiovascular disease, or a combination of these risk factors.
Obesity is also a risk factor for nonalcoholic steatohepatitis (which may lead to cirrhosis) and for reproductive system disorders, such as a low plasma testosterone Some Trade Names
DELATESTRYL
level in men and polycystic ovary syndrome in women.
Obstructive sleep apnea can result if excess fat in the neck compresses the airway during sleep. Breathing stops for moments, as often as hundreds of times a night .This disorder, often undiagnosed, can cause loud snoring and excessive daytime sleepiness and increases the risk of hypertension, cardiac arrhythmias, and metabolic syndrome.
Obesity may cause the obesity-hypoventilation syndrome (Pickwickian syndrome). Impaired breathing leads to hypercapnia, reduced sensitivity to CO2 in stimulating respiration, hypoxia, cor pulmonale, and risk of premature death. This syndrome may occur alone or secondary to obstructive sleep apnea.
Osteoarthritis and tendon and fascial disorders may result from obesity. Skin disorders are common; increased sweat and skin secretions, trapped in thick folds of skin, are conducive to fungal and bacterial growth, making intertriginous infections especially common. Being overweight probably predisposes to cholelithiasis, gout, deep venous thrombosis and pulmonary embolism, and many cancers (especially colon and breast cancers).
Obesity leads to social, economic, and psychologic problems as a result of prejudice, discrimination, poor body image, and low self-esteem. For example, people may be underemployed or unemployed.
Diagnosis
  • BMI
  • Waist circumference
  • Sometimes body composition analysis

In adults, BMI, defined as weight (kg) divided by the square of the height (m2), is used to screen for overweight or obesity. BMI of 25 to 29.9 kg/m2 indicates overweight; BMI 30 kg/m2 indicates obesity However, BMI is a crude screening tool and has limitations in many subpopulations. BMI is age- and race-specific; its use is limited in children and the elderly. In children and adolescents, overweight is BMI at the 95th percentile based on age- and sex-specific CDC growth charts at the.Asians, Japanese, and many aboriginal populations have a lower cut-off (23 kg/m2) for overweight. In addition, BMI may be high in muscular athletes who lack excess body fat, and normal or low in formerly overweight people who have lost muscle mass.
The risk of metabolic and cardiovascular complications due to obesity is determined more accurately by the following:
  • Other risk factors, particularly a family history of type 2 diabetes or premature cardiovascular disease
  • Waist circumference
  • Plasma triglycerides


Table 2
Body Mass Index (BMI)
Normal*
Overweight
Obese
Extremely obese
BMI
19–24
25–29
30–34
35–39
40–47
48–54
Height (inches)
Body Weight (pounds)
60–61
97–127
128–153
153–180
179–206
204–248
245–285
62–63
104–135
136–163
164–191
191–220
218–265
262–304
64–65
110–144
145–174
174–204
204–234
232–282
279–324
66–67
118–153
155–185
186–217
216–249
247–299
297–344
68–69
125–162
164–196
197–230
230–263
262–318
315–365
70–71
132–172
174–208
209–243
243–279
278–338
334–386
72–73
140–182
184–219
221–257
258–295
294–355
353–408
74–75
148–192
194–232
233–272
272–311
311–375
373–431
76
156–197
205–238
246–279
287–320
328–385
394–443
*BMIs less than those listed as normal are considered underweight.
Calculations are done using metric units (kg, m), but table is presented in inches and pounds for US readers.

The waist circumference that increases risk of complications due to obesity varies by ethnic group and sex:
  • White men: > 93 cm (> 36.6 in), particularly > 101 cm (> 39.8 in)
  • White women: > 79 cm (> 31.1 in), particularly > 87 cm (> 34.2 in)
  • Asian Indian men: > 78 cm (> 30.7 in), particularly > 90 cm (> 35.4 in)
  • Asian Indian women: > 72 cm (> 28.3 in), particularly > 80 cm (> 31.5 in)

Body composition analysis: Body composition—the percentage of body fat and muscle—is also considered when obesity is diagnosed. Although probably unnecessary in routine clinical practice, body composition analysis can be helpful if clinicians question whether elevated BMI is due to muscle or excessive fat.
The percentage of body fat can be estimated by measuring skinfold thickness (usually over the triceps) or determining mid upper arm area.Bioelectrical impedance analysis (BIA) can estimate percentage of body fat simply and noninvasively. BIA estimates percentage of total body water directly; percentage of body fat is derived indirectly. BIA is most reliable in healthy people and in people with only a few chronic disorders that do not change the percentage of total body water (eg, moderate obesity, diabetes mellitus). Whether measuring BIA poses risks in people with implanted defibrillators is unclear.
Underwater (hydrostatic) weighing is the most accurate method for measuring percentage of body fat. Costly and time-consuming, it is used more often in research than in clinical care. To be weighed accurately while submerged, people must fully exhale beforehand.
Imaging procedures, including CT, MRI, and dual-energy x-ray absorptiometry (DEXA), can also estimate the percentage and distribution of body fat but are usually used only for research.
Other testing: Obese patients should be screened for obstructive sleep apnea with an instrument such as the Epworth Sleepiness Scale and often the apnea-hypopnea index (total number of apnea or hypopnea episodes occurring per hour of sleep.This disorder is often underdiagnosed, and obesity increases the risk.
Fasting plasma glucose and lipids should be measured routinely in patients with a large waist circumference or a family history of type 2 diabetes mellitus or premature cardiovascular disease.
Prognosis Untreated, obesity tends to progress. The probability and severity of complications are proportional to the absolute amount of fat, the distribution of the fat, and absolute muscle mass. After weight loss, most people return to their pretreatment weight within 5 yr, and accordingly, obesity requires a lifelong management program similar to that for any other chronic disorder.
Treatment
  • Nutrition management
  • Physical activity
  • Behavioral therapy
  • Drugs (eg, sibutramine Some Trade Names
    MERIDIA
     
    , orlistat Some Trade Names
    ALLI
    XENICAL
  • Bariatric surgery

Weight loss of even 5 to 10% improves overall health and well-being and in particular helps reduce risk of cardiovascular disorders and type 2 diabetes. Weight loss can lead to improvement in patients with obstructive sleep apnea, but sometimes a lot of weight must be lost for the disorder to resolve.
Support from health care practitioners, peers, and family members and various structured programs can help with weight loss and weight maintenance.
Nutrition: A normal eating pattern is important. People who miss breakfast tend to passively consume too many calories later in the day. Patients should eat small meals and avoid or carefully choose snacks. Low-fat (particularly very low saturated fat), high-fiber diets with modest calorie restriction (by 600 kcal/day) and substitution of some protein for carbohydrate appear to have the best long-term outcome. Fresh fruits and vegetables and salads should be substituted for refined carbohydrates and processed food, and water for soft drinks or juices. Alcohol consumption should be limited to moderate levels. Foods with a low glycemic index  and marine fish oils or monounsaturated fats derived from plants (eg, olive oil) reduce the risk of cardiovascular disorders and diabetes. Low-fat dairy products are also part of a healthy diet. Patients need an adequate amount of vitamin D, preferably obtained by exercising outdoors in the sunshine.
Use of meal replacements has proven efficacy; use can be ongoing or intermittent. Diets that require unusual eating habits should be avoided. They are unlikely to be maintained, and weight increases when patients resume previous poor eating habits. Diets of < 1200 kcal/day cannot be sustained, but such diets are sometimes needed to achieve rapid short-term weight loss (eg, to prepare for surgery, to lessen obstructive sleep apnea). Diets of < 800 kcal/day do not produce greater weight loss and are less well tolerated.
Physical activity: Exercise increases energy expenditure, BMR, and diet-induced thermogenesis. Exercise also seems to regulate appetite to more closely match caloric needs. Other benefits include
  • Increased insulin sensitivity
  • Improved plasma lipid profile
  • Lower BP
  • Better aerobic fitness
  • Improved psychologic well-being

Strengthening (resistance) exercises increase muscle mass. Because muscle tissue burns more calories at rest than does fat tissue, increasing muscle mass produces lasting increases in BMR. Exercise that is interesting and enjoyable is more likely to be sustained. A combination of aerobic and resistance exercise is better than either alone.
Behavioral therapy: Behavioral therapy aims to improve eating habits and physical activity level. Rigid dieting is discouraged in favor of healthy eating. Common-sense measures include the following:
  • Avoiding high-calorie snacks
  • Choosing healthful foods when dining out
  • Eating slowly
  • Substituting a physically active hobby for a passive one

Social support, cognitive therapy, and stress management may help, particularly during the lapses usually experienced during any long-term weight loss program. Self-monitoring is useful, and maintenance of a diet diary is particularly effective.
Drugs: Drugs may be used if BMI is > 30 or if BMI is > 27 and patients have complications (eg, hypertension, insulin resistance). Most weight loss due to drug treatment is modest (5 to 10%) at best and occurs during the first 6 mo; not all patients benefit. Drugs are more useful for maintaining weight loss but must be continued indefinitely for weight loss to be maintained. Premenopausal women taking systemically acting drugs for weight control should use contraception.
Sibutramine Some Trade Names
MERIDIA
is a centrally acting appetite suppressant that produces dose-related weight loss. The usual starting dose is 10 mg po once/day; the dose can be decreased to 5 mg or increased to 15 mg. Common adverse effects are headache, dry mouth, insomnia, and constipation; the most common serious one is hypertension. Cardiovascular disorders, particularly poorly controlled hypertension, are contraindications.
Orlistat Some Trade Names
ALLI
XENICAL
 
inhibits intestinal lipase, decreasing fat absorption and improving blood glucose and lipids. Because orlistat Some Trade Names
ALLI
XENICAL
is not absorbed, systemic effects are rare. Flatus, oily stools, and diarrhea are common but tend to resolve during the 2nd yr of treatment. A dose of 120 mg po tid should be taken with meals that include fat. A vitamin supplement should be taken at least 2 h before or after taking orlistat Some Trade Names
ALLI
XENICAL
 
. Malabsorption and cholestasis are contraindications; irritable bowel syndrome and other GI disorders may make orlistat Some Trade Names
ALLI
XENICAL
difficult to tolerate. Orlistat Some Trade Names
ALLI
XENICAL
is available OTC.
Other OTC weight-loss drugs are not recommended. Some (eg, caffeine, ephedrine Some Trade Names
PRETZ-D
, guarana, phenylpropanolamine) may be marginally effective, but their adverse effects outweigh their advantages. Others (eg, brindleberry, l-carnitine, chitosan, pectin, grapeseed extract, horse chestnut, chromium picolinate, fucus vesiculosus, ginkgo biloba) have not been shown to be effective and may have adverse effects.
Surgery: Surgery is the most effective treatment for extremely obese patients .Special Populations
Obesity is a particular concern in children and the elderly.
Children: Childhood obesity is even more worrisome than adult obesity. For obese children, complications are more likely because they are obese longer. About 20 to 25% of children and adolescents are overweight or obese. Risk factors for obesity in infants are low birth weight and maternal obesity, diabetes, and smoking. After puberty, food intake increases; in boys, the extra calories are used to increase protein deposition, but in girls, fat storage is increased.
For obese children, psychologic complications (eg, poor self-esteem, social difficulties, depression) and musculoskeletal complications can develop early. Some musculoskeletal complications, such as slipped capital femoral epiphyses, occur only in children. Other early complications may include obstructive sleep apnea, insulin resistance, hyperlipidemia, and nonalcoholic steatohepatitis. Risk of cardiovascular, respiratory, metabolic, hepatic, and other obesity-related complications increases when these children become adults.
Risk of obesity persisting into adulthood depends partly on when obesity first develops:
  • During infancy: Low risk
  • Between 6 mo and 5 yr: 25%
  • After 6 yr: > 50%
  • During adolescence if a parent is obese: > 80%

In children, preventing further weight gain, rather than losing weight, is a reasonable goal. Diet should be modified, and physical activity increased. Increasing general activities and play is more likely to be effective than a structured exercise program. Participating in physical activities during childhood may promote a lifelong physically active lifestyle. Drugs and surgery are avoided but, if complications of obesity are life threatening, may be warranted.
Measures that control weight and prevent obesity in children may benefit public health the most. Such measures should be implemented in the family, schools, and primary care programs.
The elderly: In the US, the percentage of obese elderly people has been increasing.
With aging, body fat increases and is redistributed to the abdomen, and muscle mass is lost, largely because of physical inactivity, but decreased androgens and growth hormone (which are anabolic) and inflammatory cytokines produced in obesity may also play a role.
Risk of complications depends on
  • Body fat distribution (increasing with a predominantly abdominal distribution)
  • Duration and severity of obesity
  • Associated sarcopenia

Increased waist circumference, suggesting abdominal fat distribution, predicts morbidity (eg, hypertension, diabetes mellitus, coronary artery disease) and mortality risk better in the elderly than BMI.
For the elderly, increased physical activity is usually preferable to dietary restriction unless restricted mobility prohibits activity; in such cases, caloric restriction may be needed to reduce weight enough to restore mobility. Physical activity also improves muscle strength, endurance, and overall well-being. Activity should include strengthening and endurance exercises.
Regardless of whether caloric restriction is considered necessary, nutrition should be optimized.
Weight-loss drugs such as sibutramine Some Trade Names
MERIDIA
or fluoxetine Some Trade Names
PROZAC
SARAFEM
are not recommended for the elderly because the possible benefits do not outweigh the adverse effects. However, orlistat Some Trade Names
ALLI
XENICAL
 
may be useful for obese elderly patients, particularly those with diabetes mellitus or hypertension. Surgery is usually best avoided, although it has proven efficacy and benefits outweigh risks in carefully selected patients.
Prevention
Regular physical activity and healthy eating improve general fitness, can control weight, and help prevent obesity and diabetes mellitus. Even without weight loss, exercise decreases the risk of cardiovascular disorders. Dietary fiber decreases the risk of colon cancer and cardiovascular disorders. Sufficient and good-quality sleep, management of stress, and moderation of alcohol intake are also important